Archivio Comunicati Stampa 2014

Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For Treating Patients With Tremor [EN] - Sep 17, 2014

Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Vercise™ Deep Brain Stimulation (DBS) System for the treatment of tremor, including ...

PER SAPERNE DI PIÙ

Boston Scientific Announces One-Year Results In The VANTAGE Clinical Study Evaluating The Vercise™ DBS System [EN] - Jun 11, 2014

Patients with Parkinson's disease (PD) treated with the Boston Scientific Corporation (NYSE: BSX) Vercise™ Deep Brain Stimulation (DBS) System demonstrated a highly significant  ...

PER SAPERNE DI PIÙ

Clinical Study Results Demonstrate Therapeutic Advantages Of The Boston Scientific Vercise™ DBS System For Patients With Parkinson's Disease [EN] - Jun 10, 2014

A new study has demonstrated a therapeutic advantage for a unique and innovative capability of the Boston Scientific (NYSE: BSX) Vercise™ Deep Brain Stimulation ...

PER SAPERNE DI PIÙ

First Patient Enrolled In Clinical Registry Assessing Boston Scientific Vercise Deep Brain Stimulation System In Patients With Parkinsons Disease [EN] - Apr 10, 2014

Boston Scientific Corporation (NYSE: BSX) has enrolled the first patient in a new registry to evaluate clinical outcomes and the economic value of  ...

PER SAPERNE DI PIÙ

Dystonia Europe And The European Parkinson’s Disease Association (Epda) Partner With Boston Scientific In Advancing Parkinson’s And Dystonia Care [EN] - Feb 24, 2014

Dystonia Europe (DE) and The European Parkinson’s Disease Association (EPDA) announced today that they are collaborating with Boston Scientific ...

PER SAPERNE DI PIÙ